CRB
Chad R. Baker Portfolio holdings
AUM
$538M
This Quarter Return
+3.74%
1 Year Return
+20.8%
3 Year Return
+87.18%
5 Year Return
+140.51%
10 Year Return
–
AUM
$250M
AUM Growth
+$250M
(-1.3%)
Cap. Flow
-$9.27M
Cap. Flow
% of AUM
-3.7%
Top 10 Holdings %
Top 10 Hldgs %
39.19%
Holding
61
New
2
Increased
2
Reduced
7
Closed
6
Top Buys
| 1 |
Teladoc Health
TDOC
|
$2.69M |
| 2 |
New York Times
NYT
|
$1.81M |
| 3 |
Analog Devices
ADI
|
$1.79M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
$1.73M |
Top Sells
| 1 |
CVS Health
CVS
|
$2.97M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
$2.68M |
| 3 |
Procter & Gamble
PG
|
$2.63M |
| 4 |
IPG Photonics
IPGP
|
$1.69M |
| 5 |
Bristol-Myers Squibb
BMY
|
$1.47M |
Sector Composition
| 1 | Healthcare | 26.32% |
| 2 | Industrials | 19.26% |
| 3 | Technology | 18.3% |
| 4 | Communication Services | 9.29% |
| 5 | Financials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Fortive
FTV
$16B
| $4.49M | 1.79% |
58,232
| – | – |
|
27
Broadcom
AVGO
$1.4T
| $4.45M | 1.78% |
18,335
| – | – |
|
28
Illumina
ILMN
$15.5B
| $4.41M | 1.76% |
15,800
| – | – |
|
29
J.M. Smucker
SJM
$11.7B
| $4.26M | 1.7% |
39,650
| – | – |
|
30
Pfizer
PFE
$142B
| $4.06M | 1.62% |
111,996
-7,250
| -6% | -$263K |
|
|
RTN
31
DELISTED
Raytheon Company
RTN
| $3.86M | 1.54% |
20,000
| – | – |
|
32
Colgate-Palmolive
CL
$68.2B
| $3.32M | 1.33% |
51,200
| – | – |
|
33
Lowe's Companies
LOW
$145B
| $3.31M | 1.32% |
34,600
| – | – |
|
34
Stryker
SYK
$149B
| $3.23M | 1.29% |
19,145
| – | – |
|
35
Walmart
WMT
$781B
| $2.83M | 1.13% |
33,000
| – | – |
|
|
36
Teladoc Health
TDOC
$1.35B
| $2.69M | 1.08% |
+46,345
| New | +$2.69M |
|
37
Comcast
CMCSA
$126B
| $2.56M | 1.02% |
78,000
| – | – |
|
38
Alphabet (Google) Class C
GOOG
$2.56T
| $2.52M | 1.01% |
2,256
| – | – |
|
39
Perrigo
PRGO
$3.23B
| $2.3M | 0.92% |
31,565
| – | – |
|
40
PepsiCo
PEP
$206B
| $2.29M | 0.91% |
21,000
| – | – |
|
41
Adobe
ADBE
$147B
| $2.19M | 0.88% |
9,000
| – | – |
|
42
CSX Corp
CSX
$60B
| $2.17M | 0.87% |
34,000
-20,000
| -37% | -$1.28M |
|
43
Zoetis
ZTS
$67.8B
| $2.11M | 0.84% |
24,818
| – | – |
|
|
ESRX
44
DELISTED
Express Scripts Holding Company
ESRX
| $1.85M | 0.74% |
24,000
| – | – |
|
|
45
New York Times
NYT
$9.63B
| $1.81M | 0.72% |
+70,000
| New | +$1.81M |
|
46
DuPont de Nemours
DD
$31.7B
| $1.69M | 0.68% |
25,640
| – | – |
|
47
AT&T
T
$208B
| $1.28M | 0.51% |
40,000
-40,211
| -50% | -$1.29M |
|
48
International Flavors & Fragrances
IFF
$17.1B
| $1.24M | 0.5% |
10,000
| – | – |
|
49
Gilead Sciences
GILD
$140B
| $1.1M | 0.44% |
15,500
| – | – |
|
50
Biogen
BIIB
$20.5B
| $1.03M | 0.41% |
3,550
| – | – |
|